Premier Research and InSilicoTrials Partner to Leverage In Silico Modeling and Simulation and Optimize Regulatory Pathways for Rare Disease Therapies

MORRISVILLE, N.C., MILAN, ITALY, TRIESTE, ITALY — Premier Research, whose mission is to help the most innovative biotech and device companies take their best ideas from concept to commercialization, and InSilicoTrials, a leader in the use of artificial intelligence (AI) and computational modeling and simulation (CM&S) to accelerate development of new therapies and medical devices, have...

Clinical Research: Phase 1 - Phase 4

Premier Research and CENTOGENE Launch Strategic Partnership to Accelerate and De-Risk Rare Disease Clinical Development

Leveraging Rare Disease Insights Powered by the CENTOGENE Biodatabank and Centralized Multiomic Laboratories in Clinical Trials MORRISVILLE, N.C., and CAMBRIDGE, Mass., ROSTOCK, Germany, and BERLIN, January 9, 2023 — Premier Research, whose mission is to help the most innovative biotech and medtech companies take their best ideas from concept to commercialization, and Centogene N.V. [Nasdaq:...

Clinical Research: Phase 1 - Phase 4

Premier Research Named Partner of Choice

Premier Research has been cited in a Clinical Leader article as the CRO partner of choice for Daré Bioscience. The article, “How To Build A Strong CRO Partnership And Find Drug Development Success,” explores criteria to keep in mind when selecting the ideal CRO partner and how a positive sponsor-CRO partnership led to success in...

State of War in Ukraine and Business Continuity

As of March 24, 2022 As the crisis in Ukraine evolves, our urgent priority remains the safety and well-being of our staff, their families, and our clinical trial patients. The situation is fluid, and we continue to adapt our response to meet the challenge. We have set in motion a comprehensive range of practical measures...

Premier Research Launches Premier Consulting Business Unit, Creating Unified Regulatory and Strategic Product Development Brand

Morrisville, N.C., February 22, 2022 — Premier Research launched Premier Consulting today by consolidating two legacy brands within its portfolio — Regulatory Professionals, Inc. (RPI) and Camargo Pharmaceutical Services. Premier Consulting is a unified strategic product development and global regulatory consulting brand positioned for market leadership in support of emerging biotech and specialty pharma companies. The new...

Clinical Research: Phase 1 - Phase 4

Empowering Oncology Patients to Maximize Study Outcomes: Strategies and Considerations for Sponsors

TORONTO (PRWEB) OCTOBER 27, 2021 — Patient recruitment comprises one of the most significant initial challenges in any oncology study but engaging and retaining these patients throughout the clinical trial can ultimately be the challenge requiring the most upfront planning and coordination. However, during initial planning, the focus is usually placed predominately on recruitment and not...

Clinical Research: Phase 1 - Phase 4

Health Decisions, A Division of Premier Research, Presents at Women’s Health Innovation Summit

Morrisville, N.C., September 13, 2021 — Health Decisions, A Division of Premier Research, will support the Women’s Health Innovation Summit as an Associate Partner for the third year. On Tuesday, September 14 from 12:10 p.m. to 12: 45 p.m. EDT, Health Decisions, an organization that provides clinical research specific to women’s health, will present a...

Data Management & Biostatistics

Premier Research Names Jennifer Nezzer Vice President of Biometrics

Morrisville, N.C., September 2, 2021 — Premier Research has appointed Jennifer Nezzer, M.S., as Vice President of Biometrics. Nezzer, an industry-recognized expert in biostatistics with more than 25 years of global clinical research experience, will head Premier’s integrated Biostatistics and Medical Writing operational departments. Premier Research is a leading provider of clinical research, product development,...

Clinical Research: Phase 1 - Phase 4

Premier Research Deepens Support for Oncology Sponsors By Expanding Oncology Leadership Team

Premier Research Names Stefan Schnydrig Chief Human Resources Officer